Publicacións nas que colabora con Olaia Pérez Martínez (4)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
2023
-
Epidemiología de la COVID-19 entre el personal de centros sanitarios y sociosanitarios del área sanitaria de A Coruña y Cee: (Pag.-e 101938)
Semergen: revista española de medicina de familia, Núm. 5, pp. 2-2